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HIGHLIGHTS 
 Joint pain in OA fluctuates over time and is associated with affective symptoms 
 Pain severity and pain variability were measured in 832 older adults with OA  
 The relation of these pain types with affective symptoms was investigated  
 More severe and stable pain was related to more affective symptoms in the older-old 
 Joint pain in older persons with OA should be measured at multiple time-points 
 
ABSTRACT  
Pain is a key symptom of Osteoarthritis (OA) and has been linked to poor mental health. Pain 
fluctuates over time within individuals, but a paucity of studies have considered day-to-day 
fluctuations of joint pain in relation to affective symptoms in older persons with OA. This 
study investigated the relationship of both pain severity and within-person pain variability with 
anxiety and depression symptoms in 832 older adults with OA who participated in the 
European Project on OSteoArthritis (EPOSA): a six-country cohort study. Affective symptoms 
were examined with the Hospital Anxiety and Depression Scale, pain severity was assessed 
with the WOMAC/AUSCAN, and intra-individual pain variability was measured using pain 
calendars assessed at baseline, 6 and 12-18 months. Age-stratified multiple linear 
regression analyses adjusted for relevant confounders showed that more pain was 
associated with more affective symptoms in older-old participants (74.1-85 years). Moreover, 
older-old participants experienced fewer symptoms of anxiety (ratio=.85, 95% CI: .77-.94), 
depression (ratio=.90, 95% CI: .82-.98) and total affective symptoms (ratio=.87, 95% CI: .79-
.94) if their pain fluctuated more. No such association was evident in younger-old participants 
(65-74.0 years). These findings imply that stable pain levels are more detrimental to mental 
health than fluctuating pain levels in older persons.  
 
Perspective: This study showed that more severe and stable joint pain levels were 
associated with anxiety and depressive symptoms in older persons with OA. These findings 
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emphasize the importance of measuring pain in OA at multiple time-points, as joint pain 
fluctuations may be an indicator for the presence of affective symptoms. 
 
KEYWORDS 
Osteoarthritis; pain variability; depressive symptoms; anxiety symptoms; older persons. 
 
 
INTRODUCTION  
Osteoarthritis (OA) is the most common form of musculoskeletal disorders worldwide 41 and a 
leading cause of functional limitations and loss of independence in later life. Chronic pain 
represents one of the key debilitating symptoms of OA 10. Moreover, OA - and in particular 
pain experienced by OA patients - has been linked to an increased risk of affective 
symptoms, such as depression 5, 6, 20, 29 and anxiety 5, 6, 29. In turn, affective symptoms may 
have a detrimental effect on pain perception 5. A recent systematic review and meta-analysis 
concluded that around 20% of persons with OA experience depressive and/or anxiety 
symptoms 35.  More insight is needed in the vicious circle in which pain, depression, and 
anxiety may continually reinforce each other over time in persons who suffer from OA. 
     The severity of pain in OA may vary greatly between individuals 11. Moreover, individuals 
may experience stable pain levels or fluctuations in pain over time 11, 32. A fluctuating course 
requires repeated measurements and is difficult to capture with commonly used instruments 
such as the Western Ontario and McMaster Universities OA Index (WOMAC) 7 and the 
Australian/Canadian Hand Osteoarthritis Index (AUSCAN) 8.  
     The association between variability in pain experience and mental health is bi-directional 
18, 21 and has been rarely studied 32. Schneider et al. 32 showed more day-to-day fluctuations 
of pain in adult patients with OA or other rheumatic diseases who had higher levels of 
depressive symptoms. Anxiety symptoms were not predictive of variability in pain scores in 
their study.  
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     To our knowledge, no study to date has focused on the effect of intra-individual pain 
variability over time on anxiety and depressive symptoms in persons with OA. The European 
Project on OSteoArthritis (EPOSA) provides a unique opportunity to examine these 
associations in older persons with OA from the general population 40. In this study, we used 
data of the EPOSA cohort to examine the relationship of both pain severity and within-person 
pain variability over time with symptoms of anxiety and depression. Presuming that a lack of 
predictability of pain is detrimental to mental wellbeing 32, it was hypothesized that more 
severe pain and greater pain variability over time would be associated with more affective 
symptoms 5, 20, 32. 
  
METHODS 
Study design and participants 
The European Project on OSteoArthritis (EPOSA) is a multi-cohort study aimed at 
investigating the personal and societal consequences of OA and its determinants, using pre-
harmonized data from six European population-based cohorts of older adults. Participating 
countries include Germany, Italy, the Netherlands, Spain, Sweden and the United Kingdom. 
Detailed information about the EPOSA design, participants and procedures of data collection 
are described elsewhere 40. In short, 2942 community-dwelling persons of 65-85 years with 
and without OA were included. Interviews and clinical assessments took place at baseline 
and after 12 to 18 months. Furthermore, immediately after the baseline and follow-up 
interview as well as 6 months after baseline, participants were asked to complete a two-week 
calendar assessing joint pain. Presence of the three most common forms of OA – knee, hip 
and hand OA – was assessed with a clinical examination based on the criteria of the 
American College of Rheumatology 3, which resulted in a total of 889 participants with clinical 
OA of the knee, hand and/or hip. For the current study, we used data from persons with 
clinical OA who did not report joint replacements or surgery in the past two weeks at the site 
of the clinical OA (N=832). All six cohort studies were approved by the Ethical Review 
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Boards of the respective institutions and all participants gave written informed consent prior 
to the start of the study. 
 
Measurements 
Pain severity 
Pain severity in the past 48 hours was measured with the WOMAC 7 (knee and hip OA) and 
AUSCAN 8 (hand OA) pain subscales at baseline and follow-up. These commonly-used 
questionnaires assess pain in five daily life situations, rated on a 0 (no pain) to 4 (extreme 
pain) scale. As the WOMAC and AUSCAN pain subscales are scored on the same scale 
(score range: 0-20), the raw scores of knee, hip and hand pain were added up, resulting in a 
total pain severity score (range 0-60). This score was then transformed to a 0-100 scale for 
comparability to other studies 7. 
 
Pain variability 
At baseline and after 6 and 12-18 months, participants completed two-week calendars 
assessing daily joint pain. On these calendars, participants indicated their amount of joint 
pain per day, ranging from 0 (no pain) to 10 (extreme pain). In addition, participants were 
asked to indicate whether they took pain medication, whether they consulted a doctor and 
whether they had surgery as a result of their joint pain. No information regarding site and 
context of the joint pain was collected. Participants from Spain did not complete the 6-month 
calendar. As a measure of individual day-to-day pain variability over a longer time period, the 
standard deviation (SD) of the scores of all available days of the three calendars was 
calculated for each participant. The more day-to-day pain variability a person reported, the 
larger the SD. At least 7 of 14 days of at least one calendar had to be completed by a 
participant in order to be included in the pain variability analyses. 
 
Affective symptoms 
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The Hospital Anxiety and Depression Scale (HADS) 44 was used to measure symptoms of 
anxiety (HADS-A, 7 items) and depression (HADS-D, 7 items) at baseline and follow-up. The 
HADS is a widely-used, self-rated measure assessing affective symptoms the participant 
experienced in the past four weeks. The total HADS score (HADS-T) is a general measure of 
total affective symptoms. Item scores range from 0 (rarely or never) to 3 (mostly or always). 
Total scores for the subscales range from 0-21, with a score of ≥8 being indicative of the 
presence of a disorder. Total scores for the combined scale range from 0-42. The HADS 
displays good reliability and validity in several medical and general population samples 9 and 
in people with OA 6. 
 
Potential effect modifiers and confounders 
We examined whether age 23, 27 and gender 25, 38 were effect modifiers in the relationship 
between pain and affective symptoms. The analyses were adjusted for the following 
confounders: age, gender (if no effect modifier), country, education level (< elementary 
school, elementary school, vocational/secondary education, or college/university education), 
smoking 15 (never, former, or current smoker), body mass index (BMI: weight in kg / height in 
m2) 26, number of chronic diseases (selected from the seven most common chronic somatic 
diseases in the older population: chronic non-specific lung disease, cardiovascular disease, 
disease of peripheral arteries, stroke, diabetes mellitus, cancer and osteoporosis), physical 
activity (in kcal/day, assessed with the LASA Physical Activity Questionnaire) 34, 36 and use of 
psychotropic medication (antidepressants, anxiolytics and/or antipsychotics use yes/no) and 
pain medication (analgesics or anti-inflammatory medication use yes/no) 1428.  
 
Statistical analysis 
Descriptive characteristics of the study sample were examined with frequencies / 
percentages for categorical variables and medians / interquartile ranges (IQRs) for skewed 
continuous variables. With the exception of age, gender and country, all descriptive statistics 
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were weighted to adjust for differences in the distributions of age and gender across the six 
samples. Weights were calculated per gender and per five-year age category, using the 
formula: W = Nexp / Nobs, where Nexp is the number of persons in a specific age/gender 
category in the European population, and Nobs is the number of persons in a specific 
age/gender category in the cohort 40. Differences between participants in the analysed 
sample and persons who dropped out after baseline were examined with chi-square (for 
dichotomous or categorical variables) or Mann Whitney (continuous variables) tests in non-
response analyses. Cronbach’s alphas were calculated for the HADS and the 
WOMAC/AUSCAN, both at baseline and at follow-up, to evaluate the reliability of the scales 
in the EPOSA sample. 
     For pain severity, both cross-sectional and longitudinal multiple linear regression analyses 
were conducted. For the cross-sectional analysis, the baseline WOMAC/AUSCAN combined 
pain score was used as predictor and the baseline HADS-A, HADS-D and HADS-T scores as 
continuous outcome variables. To examine the relationship between pain severity and 
affective symptoms over time, the baseline WOMAC/AUSCAN combined pain score was 
used as predictor, the HADS-A, HADS-D and HADS-T scores after 12-18 months, 
respectively, as outcomes and the respective baseline HADS score as additional covariate to 
control for baseline levels of affective symptoms. 
     To study whether intra-individual pain variability over time affects affective symptoms, 
multiple linear regression analyses were performed with the individual joint pain SDs 
(calculated from the three pain calendars) as predictor and the three HADS scores at 12-18 
months as outcomes. A potential drawback of using the SD of the individual pain scores as a 
measure of pain variability is that the SD is the same for persons who report the same 
magnitude of fluctuations, regardless of their mean pain score. For instance, two persons 
with mean pain levels of 0 and 10, respectively, who experience no pain fluctuations, will 
both have an SD of 0. For this reason, we adjusted all pain variability analyses for the 
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individual mean joint pain score, calculated from all available joint pain scores on the 
calendars (similar to the calculation of the SD pain variablility score). 
     To study possible effect modification by age and gender, an interaction term of the 
predictor with the potential effect modifier was created. This interaction term was added to 
the unadjusted analyses. If the p-value of the interaction term was <.10, effect modification 
was considered to be present and stratified analyses were conducted.  
     To examine the robustness of the effects, we analyzed two models. In Model 1, we 
adjusted for country, age and gender (if no effect modifier). In Model 2, we additionally 
adjusted for education level, smoking, BMI, number of chronic diseases, physical activity and 
use of psychotropic and pain medication. 
     We conducted pre-planned sensitivity analyses for both pain severity and pain variability 
omitting persons who reported taking psychotropic medications, as these drugs may not only 
decrease affective symptoms, but also alleviate pain 28. 
     As the score distribution of all three HADS measures was skewed to the right, the 
following natural log transformation was conducted on the HADS scores: Ln(1+HADS score). 
The regression coefficients and confidence intervals (CIs) from the regression analyses were 
back-transformed to obtain interpretable ratios. These ratios can easily be converted into a 
percentage of change in the outcome variable (affective symptoms) per one unit change in 
the predictor (pain). As a one-unit increase/decrease on the pain severity scale of 0-100 is 
very small, a more meaningful 10-unit increase/decrease 4 was derived by calculating 
ratio^10. A two-sided p-value of .05 was regarded as statistically significant. All analyses 
were conducted with SPSS version 22 (SPSS Inc. Chicago, IL, USA). 
 
RESULTS 
Characteristics of the study population can be found in Table 1. Over two-thirds of the 
participants were female (70.2%) and the median age was 74.0 years. Of the 832 
participants in the present analyses, 67.0% had OA at one site, 26.6% at two sites and 6.5% 
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at all three sites. The median range of fluctuations in joint pain within one calendar (two 
weeks) was 3 points (IQR 2-4, range 0-10) for the baseline pain calendar and 2 (IQR 1-4, 
range 0-10) for the 6 and 12-18 months pain calendars.  
     Cronbachs alphas of the HADS-A, D and T at baseline and follow-up varied between .736 
and .859, indicating good reliability of the scale. Similarly, the reliability of the 
WOMAC/AUSCAN pain severity scale was also good (Cronbach’s alpha .891 and .908 for 
the baseline and follow-up scales, respectively).  
     In non-response analyses for pain variability, participants in the analyzed sample were 
compared to persons who dropped out of the study or did not complete at least 7 days on at 
least one pain calendar (N=69). At baseline, 85.2% of the participants completed ≥7 days of 
the calendar. At 6 months, 57.7% completed ≥7 days (Spain not taken into account) and at 
12-18 months, 58.5% completed ≥7 days. At baseline, non-responders to the pain calendar 
were older (p<.001) and had more depressive symptoms (p=.019), compared to participants 
who did complete at least 7 days. At 6 months, persons who dropped out or did not complete 
the calendar were older (p=.029), lower educated (p=.009), had more anxiety (p<.001) and 
depressive symptoms (p=.001), more severe pain (p=.043), more chronic diseases (p=.044) 
and higher BMI (p=.047). At 12-18 months, this pattern was similar, with the addition that 
non-responders were more often female (p=.022) and did not have a higher BMI compared 
to the responders to the calendar. 
 
---Insert Table 1 about here--- 
 
Pain severity 
Cross-sectional analyses: In the cross-sectional baseline analyses, gender was not an effect 
modifier. However, age was a significant effect modifier for anxiety (p<.001) and total 
affective symptoms (p=.002), but not for depressive symptoms (p=.22). Therefore, analyses 
were stratified at the median age (74.0 years) for anxiety and total affective symptoms and 
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analyses for depressive symptoms were conducted in the group as a whole (see Table 2). 
The regression analyses showed that, adjusted for relevant confounders, greater pain 
severity was associated with more anxiety (ratio=1.011, p<.001) and total affective symptoms 
(ratio=1.007, p=.011) in persons over 74 years (‘older old’), but not in persons between 65 
and 74 years (‘younger old’; ratio=1.002, p=.43 and ratio=1.004, p=.12, respectively). In the 
total group, more severe pain was associated with more depressive symptoms (ratio=1.006, 
p=.001). Accordingly, a 10-unit increase in pain severity corresponded to a 11.6% increase in 
anxiety symptoms and a 7.2% increase in total affective symptoms in persons >74 years, 
and with a 6.2% increase in depressive symptoms in the total group. 
Longitudinal analyses: Contrary to the cross-sectional analyses, age was not an effect 
modifier in the longitudinal analyses of pain severity. However, sex was a significant effect 
modifier for anxiety and total affective symptoms (p=.002 and .021, respectively; HADS-D: 
p=.21). Hence, analyses for anxiety and total affective symptoms were conducted separately 
for males and females and analyses for depressive symptoms were conducted in the total 
group (see Table 2). Adjusted for confounding, more severe pain at baseline was associated 
with more affective symptoms at follow-up in males (ratio=1.009, p=.022) but not in females 
(ratio=0.99, p=.78). In the total group, more severe pain at baseline was associated with 
more depressive symptoms at follow-up (ratio=1.006, p=.002). In accordance, a 10-unit 
increase in baseline pain severity corresponded to a 9.4% increase in total affective 
symptoms at follow-up in males and a 6.2% increase in depressive symptoms in the total 
group.  
Sensitivity analyses: the sensitivity analyses without persons who use psychotropic 
medications (N=178) did not change any of the conclusions (data not shown but available on 
request from the author). 
                                        
---Insert Table 2 about here---                                                                                                                                                                           
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Pain variability 
Table 3 displays the results of the pain variability analyses. Gender was not a significant 
effect modifier. However, age was a significant effect modifier for all three HADS outcomes 
(HADS-A: p=.002; HADS-D: p=.004; HADS-T: p=.001). Therefore, all analyses were 
conducted separately for the two age groups, again stratified at the median age. Greater pain 
variability over 12-18 months was significantly associated with lower anxiety (ratio=.85, 
p=.002), depressive (ratio=.90, p=.018) and total affective symptoms (ratio=.87, p=.002) after 
12-18 months in the older-old participants. In accordance, a 1-unit increase in pain variability 
was associated with a 15% lower anxiety score, a 10% lower depression score and a 13% 
lower affective symptoms score in persons with OA over 74 years. No statistically significant 
associations between pain variability and affective symptoms were observed in participants 
between 65 and 74 years of age. 
Sensitivity analyses: the sensitivity analyses without persons who use psychotropic 
medications (N=178) did not change any of the conclusions (data not shown but available on 
request from the author). 
 
---Insert Table 3 about here--- 
 
 
DISCUSSION 
Pain is a common and debilitating symptom of OA that can have substantial consequences 
for daily life. The present study investigated whether pain severity and pain fluctuations over 
time in older persons with OA from the general European population were associated with 
symptoms of anxiety and depression. The results demonstrated that more severe pain was 
associated with more depressive symptoms. In addition, higher pain severity in persons over 
74 years (‘older-old persons’) was associated with more anxiety and total affective 
symptoms. Over time, depressive symptoms became worse when pain severity increased. In 
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males, total affective symptoms increased with increasing pain severity. Previous studies 
have also indicated that pain severity is related to symptoms of anxiety and depression (refs 
4-6). The results from the EPOSA study strenghten these findings by demonstrating the 
association in a large sample of community-dwelling people with OA from multiple countries. 
     Day-to-day pain variability was assessed with three two-week pain calendars over a time 
course of 12-18 monhts. The calendars showed substantial individual day-to-day fluctuations 
of pain levels. Contrary to our expectations, more fluctuations in joint pain were associated 
with less anxiety, depressive and total affective symptoms in the older-old persons. In the 
younger-old participants (65-74 years), pain variability was not significantly associated with 
affective symptoms. 
Similar to the study by Schneider et al. 32, we expected to find more affective symptoms in 
persons with more fluctuating pain levels, possibly because of lack of control over and 
predictability of pain episodes. However, we found the opposite pattern. There are some 
differences between our study and Schneider’s study that may explain this discrepancy. For 
instance, the study by Schneider recruited patients with OA and other rheumatic diseases 
from clinics, whereas we investigated a population-based sample with (clinical) OA. 
Furthermore, Schneider et al. assessed pain in general, whereas we specifically asked about 
joint pain. Finally, the sample size of the study by Schneider was substantially smaller 
(N=300) than the sample size of the present study (N=832). 
     An explanation for the observed pain variability results might be that more predictable, 
stable and chronic pain levels activate feelings of hopelessness and lack of perspective 37. In 
addition, persons who also have ‘good days’ may be better able to withstand the ‘bad days’, 
in contrast to persons who have the same, chronic pain level every day. The latter group may 
also experience more interference with daily life functioning. Furthermore, evidence suggests 
that maladaptive plastic brain changes occur in persons with chronic pain, that do not occur 
in person with more acute pain. These changes may alter pain perception and are related to 
depression 13, 16. 
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     The negative association between pain variability and affective symptoms was observed 
in the age group over 74 years only. The cross-sectional pain severity analyses showed a 
similar pattern. Older persons may have fewer effective coping strategies due to more 
morbidity and/or frailty, compared to younger persons 17, 19, 31. In attempting to explain this 
age difference further, we looked at differences in pain and affective symptoms between 
these two age groups in our sample. The older-old group did not experience more severe or 
more fluctuating pain levels, but did report more depressive and total affective symptoms 
than their younger-old counterparts. This finding may reflect the mutually reinforcing effect of 
pain and affective symptoms in the older age group 5, 43. Our age-stratified results are in 
contrast with the study by Sanders et al., who found that older age did not influence the 
relationship between pain and depression 31. However, the study by Sanders et al. was 
conducted with older persons from the general population; not in a specific OA sample. 
     As the minimally important difference (MID) in HADS scores has rarely been studied, it is 
difficult to draw conclusions about whether the observed association between pain severity 
and variability and affective symptoms is clinically meaningful. One study involving patients 
with moderate to severe chronic obstructive pulmonary disease showed that the MID for their 
study sample was 1.5 points 30. this MID can be taken as an example for the EPOSA study, 
but it should be kept in mind that the COPD sample differed from the EPOSA sample in 
multiple ways. As we calculated ratios in our paper, it depends on the baseline HADS score 
whether a change is clinically meaningful. Our analyses showed that a reduction in pain 
severity or variability was associated with up to 15% lower HADS scores. Hence, for higher 
baseline HADS scores, this change is clinically meaningful. One could argue that this change 
is especially relevant for persons with higher baseline HADS scores, as they experience the 
most affective symptoms.  
     This study combines several strengths. First, EPOSA is a large study with a pre-
harmonized dataset including prospective cohort data from persons with OA from six 
European countries. Presence of OA was determined with standardized assessments 
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methods. The study samples were drawn from the general population, which means that we 
have data from persons with OA ranging from mild to severe and from persons who did and 
did not receive care for their OA. This study characteristic increases the generalizability of 
our results. Because of the large dataset, we were able to adjust for many relevant 
confounders and examine effect modification. Another asset is that we analyzed day-to-day 
pain variability with multiple joint pain calendars over a large time range, which is a novel and 
promising way of analyzing pain in OA. To our knowledge, no other study has focused on the 
effect of pain variability over time on anxiety and depressive symptoms in persons with OA.  
     This study also has some limitations. First, we did not ask the participants about other 
types of pain that they may have had at the same time as their joint pain, so we were not 
able to adjust for this potentially important confounder. Second, the pain calendar at 12-18 
months was completed after the HADS interview, whereas we defined the HADS as our 
dependent variable. However, the time frame between these measurements was rather short 
(1 day to two weeks), as the calendar was started the day after the interview. Leaving the 
third pain calendar out would not only reduce the power of our analyses, but would also 
mean that the HADS would be measured six months after the last pain calendar, which is a 
much longer time frame. Third, the information from the pain calendar was not specific 
enough to determine the site and context of the joint pain. Fourth, the calendars were filled 
out by hand, without electronic time stamps. Although this paper-and-pen method is 
preferred by part of the older population, it is prone to ‘backfilling’ which could potentially 
harm data quality.  
     A potential methodological issue is the use of the SD of all available joint pain scores as a 
measure of pain variability. We combined pain scores from the three calendars that were  
relatively far apart in time. Correlations between pain variability scores of each calendar were 
moderate in strength (Spearman’s rho: .409 - .571, all p<.001), indicating that the three time 
points are not dissimilar. Moreover, individual SD scores may suffer from relatively low 
reliability 42. This potential issue is more pronounced if the number of observations is low. In 
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most cases, the SD was calculated from 3*14=42 observations. Potentially, this number is 
not sufficient to reach high reliability, which may have led to an underestimation of the 
results. Future research should examine whether the use of more observations can create a 
more reliable pain variability score.  
     The nonresponse analyses revealed that the persons with the highest pain and affective 
symptom levels were lost to follow-up, which may have attenuated our results. Previous 
research, however, indicates that this loss of follow-up data is not likely to be problematic 39. 
Finally, despite the longitudinal design, it is still difficult to draw firm conclusions about the 
causality of pain severity / variability and affective symptoms. Previous research suggests 
that the relationship may even be bidirectional 5, 33. 
     The evidence from this study suggests that persons with OA experience substantial day-
to-day fluctuations of pain levels. This result is in accordance with another study that also 
observed that changes in pain were associated with changes in mood in persons with OA 2, 
22. These results emphasize the importance of measuring  pain variability in persons with OA, 
as it may shed a different light on experienced pain and its consequences, compared to 
measuring pain at only one time-point 2. 
     At the moment, treatment for depression and anxiety in persons with OA is suboptimal 1, 
43. Pain, anxiety and depression are risk factors for further functional decline in OA 12 and the 
disease burden increases if a person experiences affective symptoms 24. Future research 
should focus on finding effective interventions for reducing (the burden of) chronic pain to 
improve mental wellbeing in older persons with OA. 
     In conclusion, the present study showed that more severe and stable joint pain levels are 
associated with more symptoms of anxiety and depression in persons over 74 years of age 
who suffer from OA. Due to the fluctuating nature of joint pain in OA, assessing pain severity 
at only one time-point is not enough to capture the whole story. Therefore, it is important to 
assess the chronicity of the pain in OA, as it may be an indicator for the presence of anxiety 
and/or depressive symptoms. 
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Table 1. Characteristics* of the EPOSA participants with clinical OA of the knee, hip, and/or hand. 
 Total group Younger old (65-74.0 yrs.) Older old (74.1-85 yrs.) 
Presence of clinical OA: 
     Knee OA 
     Hip OA 
     Hand OA 
 
N=832  
523 (63.3) 
162 (19.7) 
468 (56.3) 
N=450 
 
 
266 (59.3) 
93 (21.1) 
263 (58.8) 
N=382  
257 (70.2) 
69 (18.2) 
205 (54.8) 
Country: 
     Germany 
     Italy 
     Netherlands 
     Spain 
     Sweden 
     United Kingdom 
 
N=832  
76 (9.1) 
185 (22.2) 
132 (15.9) 
173 (20.8) 
157 (18.9) 
109 (13.1) 
N=450  
47 (10.4) 
109 (24.2) 
53 (11.8) 
76 (16.9) 
115 (25.6) 
50 (11.1) 
N=382  
29 (7.6) 
76 (19.9) 
79 (20.7) 
97 (25.4) 
42 (11.0) 
59 (15.4) 
Gender: 
     Females 
     Males 
 
N=832  
548 (70.2) 
248 (29.8) 
N=450  
322 (71.6) 
128 (28.4) 
N=382  
262 (68.6) 
120 (31.4) 
Age 
 
N=832 74.0 [70.0–78.0] N=450 70.7 [68.0-72.0] N=382 78.0 [76.0-81.0] 
Education level: 
     Elementary school not completed 
     Elementary school completed 
     Vocational or general secondary education 
     College or university education 
 
N=831  
127 (15.6) 
307 (37.3) 
263 (31.4) 
134 (15.8) 
N=449  
50 (11.3) 
152 (34.7) 
161 (35.3) 
86 (18.7) 
N=382  
77 (21.0) 
155 (40.4) 
102 (26.4) 
48 (12.2) 
Smoking: 
     Never  
     Current  
     Former 
 
N=828 
 
 
445 (55.0) 
46 (5.9) 
337 (39.1) 
N=449  
239 (53.2) 
34 (8.3) 
176 (38.5) 
N=379  
206 (57.2) 
12 (3.0) 
161 (39.8) 
Body mass index (kg/m2) 
 
N=810 27.8 [24.8-31.2] N=441 27.5 [24.6-30.9] N=369 28.2 [25.2-31.3] 
Number of chronic diseases 
 
N=824 1 [0-2] N=445 1 [0-2] N=379 1 [1-2] 
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Physical activity (kcal/day) 
 
N=798 686 [428–1058] N=437 749 [494-1176] N=361 597 [349-940] 
Use of psychotropic medication 
 
N=832 178 (21.7) N=450 82 (17.5) N=382 96 (27.1) 
Use of analgesic/anti-inflammatory medication 
 
N=831 265 (31.6) N=449 143 (30.5) N=382 122 (32.9) 
Pain severity (WOMAC / AUSCAN)** 
     Baseline 
     Follow-up 
 
 
N=823 
N=646 
 
15.0 [10.0-25.0] 
15.0 [6.7-26.7] 
 
N=447 
N=367 
 
15.0 [8.3-23.3] 
13.4 [5.0-25.0] 
 
N=376 
N=279 
 
16.7 [10.0-26.7] 
16.7[6.7-28.3] 
Pain variability (from Pain Calendar) *** 
 
N=762 1.3 [0.9-1.9] N=428 1.3 [0.9-1.8] N=334 1.3 [0.9-1.9] 
HADS 
     Baseline:  
        HADS-A 
        HADS-D 
        HADS-T 
     Follow-up:  
        HADS-A 
        HADS-D 
        HADS-T 
 
N=802 
 
 
 
N=650 
 
 
5 [3-9] 
4 [2-7] 
10 [5-15] 
 
5 [2-7] 
3 [1-6] 
8 [4-13] 
 
N=437 
 
 
 
N=370 
 
 
6 [3-9] 
4 [1-6] 
9 [5-15] 
 
4 [2-8] 
3 [1-6] 
8 [4-13] 
 
N=365 
 
 
 
N=280 
 
 
5 [3-8] 
5 [2-7] 
10 [6-15] 
 
5 [2-7] 
4 [2-7] 
9 [5-14] 
Values column are displayed as N (%) or as median [IQR]. * With exception of age, gender and country, descriptive statistics are weighted; the N is unweighted.  
** Score range: 0-100. *** Pain variability displayed in individual standard deviation units. OA: osteoarthritis; HADS-A/D/T: Hospital Anxiety and Depression  
Scale –Anxiety/Depression/Total scale score. WOMAC: Western Ontario McMasters Universities Osteoarthritis Index; AUSCAN: Australian / Canadian hand  
Osteoarthritis Index. 
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Table 2.  Cross-sectional and longitudinal associations between pain severity and affective symptoms, analyzed with multiple  
linear regression analysis, displayed as ratio per 10-point difference/change in WOMAC/AUSCAN pain severity (95% CI). 
Cross-sectional Total group  Younger old (65.0-74.0 yrs.)  Older old (74.1-85 yrs.) 
 Model 1
a
 Model 2
b
  Model 1
a
 Model 2
b
  Model 1
a
 Model 2
b
 
HADS-A   1.04 (.99, 1.09) 1.02 (.97, 1.07)  1.14*** (1.08, 1.21) 1.12*** (1.05, 1.19) 
HADS-D 1.08*** (1.05, 1.13) 1.06** (1.02, 1.11)     
HADS-T   1.06* (1.01, 1.12) 1.04 (.99 1.09)  1.12*** (1.06, 1.17) 1.07* (1.02, 1.13) 
Longitudinal Total group  Females  Males 
 Model 1
a
 Model 2
b
  Model 1
a
 Model 2
b
  Model 1
a
 Model 2
b 
HADS-A   .97 (.93, 1.01) .98 (.94, 1.02)  1.10* (1.02, 1.20) 1.08 (1.00, 1.17) 
HADS-D 1.06** (1.02, 1.09) 1.06** (1.02, 1.09)     
HADS-T   .99 (.95, 1.03) .99 (.95, 1.04)  1.09* (1.02, 1.17) 1.09* (1.01, 1.17) 
Model 1: adjusted for sex, age and country. b Model 2: additionally adjusted for education level, smoking, BMI, chronic diseases, physical activity and use of  
psychotropic and pain medication. HADS-A/D/T: Hospital Anxiety and Depression Scale – Anxiety/Depression/Total scale. *p<.05; ** p<.01; *** p<.001. 
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Table 3. Longitudinal associations between pain variability and affective symptoms in 
persons with OA, analyzed with multiple linear regression analysis, displayed as ratio  
(95% CI). 
 Younger old (65.0-74.0 yrs.)  Older old (74.1-85 yrs.) 
 Model 1
a
 Model 2
b
  Model 1
a
 Model 2
b
 
HADS-A 1.07 (.97, 1.18) 1.07 (.97, 1.18)  .86** (.77, .95) .85** (.77, .94) 
HADS-D 1.02 (.94, 1.11) 1.02 (.94, 1.12)  .91 (.83, 1.00) .90* (.82, .98) 
HADS-T 1.01 (.92, 1.10) 1.04 (.95, 1.15)  .90* (.82, .98) .87** (.79, .94) 
Pain variability measured with individual SDs of joint pain scores on a maximum of 3 pain calendars.  
Model 1: adjusted for sex, age and country. b Model 2: additionally adjusted for education level, smoking,  
BMI, chronic diseases, physical activity and use of psychotropic and pain medication. HADS-A/D/T:  
Hospital Anxiety and Depression Scale – Anxiety/Depression/Total scale. *p<.05; ** p<.01. 
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